Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen.
Ahmad Aizat Abdul AzizMd Salzihan Md SallehMaya Mazuwin YahyaAndee Dzulkarnaen ZakariaRavindran AnkathilPublished in: Asian Pacific journal of cancer prevention : APJCP (2021)
Our results demonstrate the potential use of CYP1B1 4325 GG variant genotype as a candidate biomarker in predicting risk of recurrence in TNBC patients undergoing TAC chemotherapy regimen.